RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

RAD51 and γH2AX nuclear foci were evaluated by immunofluorescence in high-grade serous ovarian cancer patient-derived cell lines, organoids, and formalin-fixed, paraffin-embedded tumor samples.